The global oligonucleotide synthesis market is expected to grow with the CAGR of 10%-12% by 2025

   January 13, 2021
According to a new market report published by Lucintel, the future of the oligonucleotide synthesis market looks promising with opportunities in research, diagnostic, and therapeutic applications. The global oligonucleotide synthesis market is expected to grow with a CAGR of 10%-12% from 2020 to 2025. The major drivers for this market are rising research activities in synthetic biology, increasing prevalence of cancer & infectious diseases, and growing demand for innovative and therapeutic techniques.

Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure. In this market, synthesized oligonucleotides, reagents & consumables, and equipment are the major offerings. Lucintel forecasts that synthesized oligonucleotides will remain the largest offering segment over the forecast period due to rising research and development activities related to oligonucleotide-based drugs.

Within this market, hospitals will remain the largest end user segment over the forecast period due to a significant number of inpatient and outpatient visits and increasing prevalance of cancer and infectious diseases.

North America will remain the largest region over the forecast period due to rising research and development activities related to life science and the increasing number of oligonucleotide-based drugs/therapies being approved by the FDA (Food and Drug Administration) in the region.

General Electric, Merck, Eurofins Scientific, Agilent Technologies, LGC Biosearch Technologies, Integrated DNA Technologies, GeneDesign, Nitto Denko Avecia, Trilink Biotechnologies, and Kaneka Eurogentec are among the major suppliers in the global oligonucleotide synthesis market.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global oligonucleotide synthesis market by offering, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Oligonucleotide Synthesis Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global oligonucleotide synthesis market by offering, application, end user, and region as follows:

By Offering [Value ($ Million) shipment analysis for 2014 – 2025]:

  • Synthesized Oligonucleotides

    • Products

      • Oligonucleotide-Based Drugs

      • Primers

      • Probes

      • Large-Scale Synthesis Oligonucleotides

      • Intermediate-Scale Synthesis Oligonucleotides

      • Linkers & Adaptors

    • Services

      • Custom Oligonucleotides

      • Pre-Designed Oligonucleotides

  • Reagents & Consumables

  • Equipment

By Application [Value ($ Million) shipment analysis for 2014 – 2025]:

  • Research

    • PCR (Polymerase Chain Reaction)

    • qPCR (Quantitative Polymerase Chain Reaction)

    • Sequencing

    • Gene Synthesis

    • Other Research Applications

  • Diagnostics

  • Therapeutics

    • DNA & Antisense Oligonucleotide-Based Therapies

    • RNAi Oligonucleotide-Based Therapies

    • CPG Oligonucleotide-Based Therapies

By End User [Value ($ Million) shipment analysis for 2014 – 2025]:

  • Academic & Research Institutes

  • Pharmaceutical & Biotechnology Companies

  • Diagnostic Laboratories

  • Hospitals

By Region [Value ($ Million) shipment analysis for 2014 – 2025]:

  • North America

  • United States

  • Canada

  • Mexico

  • Europe

  • United Kingdom

  • Germany

  • France

  • Asia Pacific

  • China

  • India

  • Japan

  • The Rest of the World

  • Brazil


This more than 150 page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit

Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti